Francesco Carli

Francesco Carli, Pietro Foini, Nicolò Gozzi et al.

The large majority of human activities require collaborations within and across formal or informal teams. Our understanding of how the collaborative efforts spent by teams relate to their performance is still a matter of debate. Teamwork results in a highly interconnected ecosystem of potentially overlapping components where tasks are performed in interaction with team members and across other teams. To tackle this problem, we propose a graph neural network model designed to predict a team's performance while identifying the drivers that determine such an outcome. In particular, the model is based on three architectural channels: topological, centrality, and contextual which capture different factors potentially shaping teams' success. We endow the model with two attention mechanisms to boost model performance and allow interpretability. A first mechanism allows pinpointing key members inside the team. A second mechanism allows us to quantify the contributions of the three driver effects in determining the outcome performance. We test model performance on a wide range of domains outperforming most of the classical and neural baselines considered. Moreover, we include synthetic datasets specifically designed to validate how the model disentangles the intended properties on which our model vastly outperforms baselines.

Martino Ciaperoni, Margherita Lalli, Simone Piaggesi et al.

Predicting cancer drug response from transcriptomic profiles is a cornerstone of precision oncology, yet the scientific value of machine learning models hinges not solely on predictive accuracy, but also on their capacity to generate reliable biological insights. Current explainability approaches in this setting are computationally costly, lack robustness, and reduce complex drug response to univariate gene importance scores, overlooking the coordinated gene activity that drives sensitivity and resistance. In this work, we present ILLUME+, a scalable post-hoc explainability framework that moves beyond single-gene assessments to capture multiple, complementary forms of explanation. Integrated into our end-to-end pipeline, ILLUME+ produces more stable gene importance scores than existing baselines, recovers established drug-gene associations and mechanisms of action, and enables AI-assisted hypothesis generation to uncover novel interaction-driven molecular signals in cancer biology.